Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Genetic mutations and molecularly-targeted drugs in hypereosinophilic syndromes].

Arerugi = [Allergy] - 1 Feb 2011

Yamada Yoshiyuki

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Fusion
Share to Hypereosinophilic Syndrome
Share to Molecular Targeted Therapy
Share to mRNA Cleavage and Polyadenylation Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Receptors, Platelet-Derived Growth Factor

Source

Identifiers

PMID: 21399396

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Genetic mutations and molecularly-targeted drugs in hypereosinophilic syndromes].PMID 21399396Read ↗

Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogeneticsSemantic proximity Read ↗

Treatment for genetic diseases.Semantic proximity Read ↗

Pharmaceutical therapies to recode nonsense mutations in inherited diseasesSemantic proximity Read ↗

[Mutation pedigree and treatment selection of Erdheim-Chester disease].Semantic proximity Read ↗

Hypereosinophilic syndromeSemantic proximity Read ↗

Specific genetic defects as targets for selective therapies. Commentary.Semantic proximity Read ↗

Finding chemical drugs for genetic diseases.Semantic proximity Read ↗

[Somatic mutation and novel strategies for personalized targeting therapy].Semantic proximity Read ↗

Pharmaceuticals Targeting Nonsense Mutations in Genetic DiseasesSemantic proximity Read ↗

[Dominant negative STAT-3 mutations in hyper-IgE syndrome].Semantic proximity Read ↗

A clonal hypereosinophilic syndrome with specific and effective therapy: a report of two cases.Semantic proximity Read ↗

[Mutations in the gene coding for the extra-cellular 1 matricial protein in lipoid proteinosis].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.